Hansa Biopharma AB (HNSA.ST) Q1 2024 Earnings

18AprExpected
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-3.71
-3.59
-3.48
-3.36

Details

Expected EPS
-3.36
Actual EPS
N/A
Surprise EPS
3.36
Surprise Percent
+100%

Description

Hansa Biopharma AB (HNSA.ST) will report earnings of for Q1 2024 on April 18, 2024.

0 Comments

Share your thoughts